The Antimalarial Drug Artesunate Attenuates Cardiac Injury in A Rodent Model of Myocardial Infarction

Shock
Areeg I KhanChristoph Thiemermann

Abstract

Ischemic heart disease remains the leading cause of morbidity and mortality in the Western world. Artesunate is the WHO-recommended drug of choice for complicated malaria (with organ failure). The administration of high doses of artesunate is safe in healthy volunteers (up to 8 mg/kg i.v.) and patients with severe malaria (2.4 mg/kg i.v.). We investigated the effects of artesunate (1 mg/kg) or its active metabolite dihydroartemisinin (DHA; 0.1 mg/kg) in a model of transient myocardial ischemia/reperfusion (I/R) and evaluated the mechanism of action of the observed cardioprotective effects of artesunate and DHA. We report here for the first time that the administration of artesunate at the onset of reperfusion attenuates the myocardial injury associated with I/R. The observed beneficial effects of artesunate are associated with activation of the PI3K/Akt/ERK 1/2 (RISK) pathway, activation of endothelial nitric oxide synthase, inhibition of glycogen synthase kinase-3β, inhibition of nuclear factor kappa B, and activation of the STAT3 (SAFE) pathway. In conclusion, as artesunate has an excellent safety profile, the above data should stimulate clinical trials in patients with acute coronary syndromes.

References

Jun 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·N J White
Dec 5, 1998·The American Journal of Tropical Medicine and Hygiene·K T BattyT M Davis
Apr 20, 2002·Current Opinion in Infectious Diseases·R K Haynes
Aug 9, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kenneth F IlettGeoffrey Edwards
Sep 18, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Daniel SchulmanDerek M Yellon
Nov 15, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Maria WartenbergHeinrich Sauer
Jul 24, 2004·Circulation Research·Roberto BolliUNKNOWN NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia
Nov 10, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sanjeev KrishnaRichard K Haynes
Aug 19, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Michael D GoodmanKaryn L Butler
Mar 3, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·E M HodelL A Decosterd
Aug 12, 2009·Cardiovascular Research·Lydia LacerdaSandrine Lecour
Sep 6, 2011·European Heart Journal·Ulrich Förstermann, William C Sessa
Mar 19, 2013·Atherosclerosis·Miguel A FriasSandrine Lecour
Sep 27, 2013·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Y WangY L Wang
May 8, 2016·Journal of the American Society of Nephrology : JASN·Jianmin ChenChristoph Thiemermann

❮ Previous
Next ❯

Citations

May 15, 2018·Shock·Rami Namas, Yoram Vodovotz
Jul 6, 2021·The Journal of Surgical Research·Liang CaiZhenyu Shi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.